Payor Coverage for both Hybrid and Standalone Sinus Balloon Dilation procedures continues to show growth year over year since 2010.
What is driving this coverage expansion? Two factors may be behind this trend:
- Balloon dilation procedures have been proven to be a safe, effective, and beneficial alternative option to FESS in patients with uncomplicated chronic rhinosinusitis
- Positive patient outcomes have motivated physician advocates to share their experiences with payors